[HTML][HTML] 13 reasons why the brain is susceptible to oxidative stress

JN Cobley, ML Fiorello, DM Bailey - Redox biology, 2018 - Elsevier
The human brain consumes 20% of the total basal oxygen (O 2) budget to support ATP
intensive neuronal activity. Without sufficient O 2 to support ATP demands, neuronal activity …

Impaired dopamine release in Parkinson's disease

KML Cramb, D Beccano-Kelly, SJ Cragg… - Brain, 2023 - academic.oup.com
Parkinson's disease is the second most common neurodegenerative disease and yet the
early pathophysiological events of the condition and sequences of dysfunction remain …

Impaired dopamine metabolism in Parkinson's disease pathogenesis

A Masato, N Plotegher, D Boassa… - Molecular …, 2019 - Springer
A full understanding of Parkinson's Disease etiopathogenesis and of the causes of the
preferential vulnerability of nigrostriatal dopaminergic neurons is still an unsolved puzzle. A …

The physiological role of α‐synuclein and its relationship to Parkinson's Disease

D Sulzer, RH Edwards - Journal of neurochemistry, 2019 - Wiley Online Library
The protein α‐synuclein has a central role in the pathogenesis of Parkinson's disease (PD).
In this review, we discuss recent results concerning its primary function, which appears to be …

Alpha-synuclein oligomers: a new hope

N Bengoa-Vergniory, RF Roberts, R Wade-Martins… - Acta …, 2017 - Springer
Alpha-synuclein is a protein implicated in Parkinson's disease and thought to be one of the
main pathological drivers in the disease, although it remains unclear how this protein elicits …

Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson's disease

M Nguyen, YC Wong, D Ysselstein, A Severino… - Trends in …, 2019 - cell.com
The discovery of genetic forms of Parkinson's disease (PD) has highlighted the importance
of the autophagy/lysosomal and mitochondrial/oxidative stress pathways in disease …

Oxidative stress and cellular pathologies in Parkinson's disease

L Puspita, SY Chung, J Shim - Molecular brain, 2017 - Springer
Parkinson's disease (PD) is a chronic and progressive neurodegeneration of dopamine
neurons in the substantia nigra. The reason for the death of these neurons is unclear; …

[HTML][HTML] Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain …

RM Wise, A Wagener, UM Fietzek, T Klopstock… - Neurobiology of …, 2022 - Elsevier
Dopamine metabolism, alpha-synuclein pathology, and iron homeostasis have all been
implicated as potential contributors to the unique vulnerability of substantia nigra …

Role of dopamine in the pathophysiology of Parkinson's disease

ZD Zhou, LX Yi, DQ Wang, TM Lim, EK Tan - Translational …, 2023 - Springer
A pathological feature of Parkinson's disease (PD) is the progressive loss of dopaminergic
neurons and decreased dopamine (DA) content in the substantia nigra pars compacta in PD …

Dopamine, oxidative stress and protein–quinone modifications in Parkinson's and other neurodegenerative diseases

E Monzani, S Nicolis, S Dell'Acqua… - Angewandte Chemie …, 2019 - Wiley Online Library
Dopamine (DA) is the most important catecholamine in the brain, as it is the most abundant
and the precursor of other neurotransmitters. Degeneration of nigrostriatal neurons of …